Neurocrine Biosciences Inc (NBIX) Com Stk NPV (CDI)

Sell:$159.51Buy:$159.58Price decreased$0.52 (0.33%)

NASDAQ:Price increased3.07%
Market closed |
Prices delayed by at least 15 minutes
Sell:$159.51
Buy:$159.58
Change:Price decreased$0.52 (0.33%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$159.51
Buy:$159.58
Change:Price decreased$0.52 (0.33%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
5 June 2026
Stephen A SherwinIndependent Director
Sell
Option/Award related
7,883$163.81$1,291,290.5832,977
5 June 2026
Stephen A SherwinIndependent Director
Sell
Option/Award related
2,549$164.44$419,156.0330,428
5 June 2026
Stephen A SherwinIndependent Director
Sell
Option/Award related
6,896$165.79$1,143,305.7723,532
5 June 2026
Stephen A SherwinIndependent Director
Sell
Option/Award related
5,829$166.56$970,859.0017,703
5 June 2026
Stephen A SherwinIndependent Director
Sell
Option/Award related
1,843$167.31$308,357.4915,860
4 June 2026
Leslie V NorwalkIndependent Director
Sell
Regular sell transaction (market)
1,250$168.06$210,071.632,838
2 June 2026
Julie Smith CookeGroup Director
Sell
Option/Award related
14,214$154.83$2,200,685.3945,097
2 June 2026
Julie Smith CookeGroup Director
Sell
Option/Award related
5,466$155.46$849,725.7839,631
2 June 2026
Julie Smith CookeGroup Director
Sell
Option/Award related
4,216$156.77$660,925.4635,415
2 June 2026
Julie Smith CookeGroup Director
Sell
Regular sell transaction (market)
9,521$157.62$1,500,662.8925,894

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
19 May 2026
Kevin Charles GormanOther Level A
Sell
Regular sell transaction (market)
245,088$154.33$37,824,872.20511,293
7 August 2025
Kevin Charles GormanOther Level A
Sell
Option/Award related
106,322$126.41$13,440,280.97514,596
9 July 2025
Jude OnyiaChief Level Officer
Sell
Option/Award related
59,819$130.46$7,803,687.6518,289
16 January 2026
Kyle W. GanoPresident/CEO
Sell
Option/Award related
34,588$132.70$4,589,979.79140,407
13 February 2026
Kevin Charles GormanOther Level A
Sell
Tax related
34,380$124.12$4,267,245.60551,293

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.